Travere Therapeutics (TVTX) PT Lowered to $18 at BofA Securities

September 27, 2024 5:59 AM

BofA Securities analyst Greg Harrison lowered the price target on Travere Therapeutics (NASDAQ: TVTX) to $18.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found